Clover Corporation Limited (ASX:CLV)
Australia
· Delayed Price · Currency is AUD | Market Cap | 158.60M |
| Revenue (ttm) | 92.50M |
| Net Income (ttm) | 8.89M |
| Shares Out | 166.07M |
| EPS (ttm) | 0.05 |
| PE Ratio | 17.95 |
| Forward PE | 18.73 |
| Dividend | 0.02 (2.00%) |
| Ex-Dividend Date | Apr 15, 2026 |
| Volume | 1,269 |
| Average Volume | 159,906 |
| Open | 0.960 |
| Previous Close | 0.955 |
| Day's Range | 0.960 - 0.960 |
| 52-Week Range | 0.375 - 1.165 |
| Beta | -0.36 |
| RSI | 51.70 |
| Earnings Date | Sep 23, 2026 |
About Clover Corporation
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquarte... [Read more]
Financial Performance
In fiscal year 2025, Clover Corporation's revenue was 86.00 million, an increase of 38.25% compared to the previous year's 62.21 million. Earnings were 7.02 million, an increase of 382.46%.
Financial StatementsNews
Clover Corp Ltd (ASX:CLV) (Q1 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion
Clover Corp Ltd (ASX:CLV) (Q1 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion
Clover Corporation Earnings Call Transcript: H1 2026
Record half-year revenue and margin growth driven by new products, diversified customer base, and operational improvements. Strong outlook for the full year with guidance of AUD 92–96 million, supported by robust demand and expanded distribution.
Clover Corporation Transcript: AGM 2025
The meeting highlighted strong revenue growth, improved margins, and a rising dividend, with strategic focus on product innovation, market diversification, and R&D. Board transitions and governance updates were addressed, while shareholders engaged on growth, risk, and new product commercialization.
Clover Corp Ltd (ASX:CLV) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Clover Corp Ltd (ASX:CLV) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Clover Corporation Earnings Call Transcript: H2 2025
Record FY2025 revenue and profit growth were driven by new products, expanded distribution, and improved margins. Outlook for FY2026 is cautious, with flat first-half revenue expected due to seasonality and customer inventory timing, but growth anticipated in the second half. Gross margins are expected to remain strong, supported by operational efficiencies and supply chain integration.
Clover Corporation Earnings Call Transcript: H1 2025
Revenue grew 38% year-over-year to AUD 37.6 million, with gross margin up to 29.6% and NPAT at AUD 2.4 million. Diversification and operational improvements drove results, and a stronger second half is expected as new products and lower-cost inputs come online.
Clover Corporation Transcript: AGM 2024
The AGM highlighted a challenging year with lower revenue and profit, but a strong recovery in the second half. Strategic investments in supply chain, new product launches, and market diversification were emphasized, with all resolutions put to poll and board confidence in future growth.